A two-part study to evaluate safety, tolerability, and pharmacokinetics of single escalating oral doses of GSK945237 and the effect of food on single oral doses of GSK945237 in healthy adult subjects.

Trial Profile

A two-part study to evaluate safety, tolerability, and pharmacokinetics of single escalating oral doses of GSK945237 and the effect of food on single oral doses of GSK945237 in healthy adult subjects.

Completed
Phase of Trial: Phase I

Latest Information Update: 16 Mar 2012

At a glance

  • Drugs GSK 945237 (Primary)
  • Indications Bacterial infections
  • Focus Adverse reactions
  • Most Recent Events

    • 13 May 2011 Status changed from suspended to completed as reported by ClinicalTrials.gov.
    • 12 Oct 2008 Status changed from recruiting to suspended as reported by ClinicalTrials.gov.
    • 28 Aug 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top